Literature DB >> 382872

Vasodilation of cat cerebral arterioles by prostaglandins D2, E2, G2, and I2.

E F Ellis, E P Wei, H A Kontos.   

Abstract

To determine the possible role that endogenously produced prostaglandins may play in the regulation of cerebral blood flow, the responses of cerebral precapillary vessels to prostaglandins (PG) D2, E2, G2, and I2 (8.1 X 10(-8) to 2.7 X 10(-5) M) were studied in cats equipped with cranial windows for direct observation of the microvasculature. Local application of PGs induced a dose-dependent dilation of large (greater than or equal to 100 microns) and small (less than 100 microns) arterioles with no effect on arterial blood pressure. The relative vasodilator potency was PGG2 greater than PGE2 greater than PGI2 greater than PGD2. With all PGs, except D2, the percent dilation of small arterioles was greater than the dilation of large arterioles. After application of prostaglandins in a concentration of 2.7 X 10(-5) M, the mean +/- standard error of the percent dilation of large and small arterioles was, respectively, 47.6 +/- 2.7 and 65.3 +/- 6.1 for G2, 34.1 +/- 2.0, and 53.6 +/- 5.5 for E2, 25.4 +/- 1.8, and 40.2 +/- 4.6 for I2, and 20.3 +/- 2.5 and 11.0 +/- 2.2 for D2. Because brain arterioles are strongly responsive to prostaglandins and the brain can synthesize prostaglandins from its large endogenous pool of prostaglandin precursor, prostaglandins may be important mediators of changes in cerebral blood flow under normal and abnormal conditions.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 382872     DOI: 10.1152/ajpheart.1979.237.3.H381

Source DB:  PubMed          Journal:  Am J Physiol        ISSN: 0002-9513


  22 in total

Review 1.  Ion channel networks in the control of cerebral blood flow.

Authors:  Thomas A Longden; David C Hill-Eubanks; Mark T Nelson
Journal:  J Cereb Blood Flow Metab       Date:  2015-11-09       Impact factor: 6.200

2.  Cyclooxygenase-2 contributes to functional hyperemia in whisker-barrel cortex.

Authors:  K Niwa; E Araki; S G Morham; M E Ross; C Iadecola
Journal:  J Neurosci       Date:  2000-01-15       Impact factor: 6.167

3.  Cerebrovascular effects of prostanoids. In-situ studies in pial arteries of the cat.

Authors:  M Wahl; L Schilling; E T Whalley
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1989-09       Impact factor: 3.000

Review 4.  Antiinflammatory and neuroprotective actions of COX2 inhibitors in the injured brain.

Authors:  Kenneth I Strauss
Journal:  Brain Behav Immun       Date:  2007-11-08       Impact factor: 7.217

5.  Prostaglandin E2, a postulated astrocyte-derived neurovascular coupling agent, constricts rather than dilates parenchymal arterioles.

Authors:  Fabrice Dabertrand; Rachael M Hannah; Jessica M Pearson; David C Hill-Eubanks; Joseph E Brayden; Mark T Nelson
Journal:  J Cereb Blood Flow Metab       Date:  2013-02-06       Impact factor: 6.200

6.  The role of prostaglandins in the endothelium-mediated vasodilatory response to hypoxia.

Authors:  R Busse; U Förstermann; H Matsuda; U Pohl
Journal:  Pflugers Arch       Date:  1984-05       Impact factor: 3.657

7.  PGF(2alpha) FP receptor contributes to brain damage following transient focal brain ischemia.

Authors:  Sofiyan Saleem; Abdullah Shafique Ahmad; Takayuki Maruyama; Shuh Narumiya; Sylvain Doré
Journal:  Neurotox Res       Date:  2009-02-11       Impact factor: 3.911

8.  Vascular amyloidosis impairs the gliovascular unit in a mouse model of Alzheimer's disease.

Authors:  Ian F Kimbrough; Stefanie Robel; Erik D Roberson; Harald Sontheimer
Journal:  Brain       Date:  2015-11-23       Impact factor: 13.501

9.  Arachidonic acid and prostaglandin endoperoxide metabolism in isolated rabbit and coronary microvessels and isolated and cultivated coronary microvessel endothelial cells.

Authors:  M E Gerritsen; C D Cheli
Journal:  J Clin Invest       Date:  1983-11       Impact factor: 14.808

10.  Protective effect of prostaglandins D2, E1 and I2 against cerebral hypoxia/anoxia in mice.

Authors:  Y Masuda; Y Ochi; Y Ochi; T Karasawa; N Hatano; T Kadokawa; M Shimizu
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1986-11       Impact factor: 3.000

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.